Cargando…

Multiallelic copy number variation in the complement component 4A (C4A) gene is associated with late-stage age-related macular degeneration (AMD)

BACKGROUND: Age-related macular degeneration (AMD) is the leading cause of vision loss in Western societies with a strong genetic component. Candidate gene studies as well as genome-wide association studies strongly implicated genetic variations in complement genes to be involved in disease risk. So...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grassmann, Felix, Cantsilieris, Stuart, Schulz-Kuhnt, Anja-Sabrina, White, Stefan J., Richardson, Andrea J, Hewitt, Alex W, Vote, Brendan J., Schmied, Denise, Guymer, Robyn H, Weber, Bernhard H.F., Baird, Paul N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835888/ https://www.ncbi.nlm.nih.gov/pubmed/27090374 http://dx.doi.org/10.1186/s12974-016-0548-0

Ejemplares similares

Comprehensive Analysis of Copy Number Variation of Genes at Chromosome 1 and 10 Loci Associated with Late Age Related Macular Degeneration
por: Cantsilieris, Stuart, et al.
Publicado: (2012)

Copy number variations and multiallelic variants in Korean patients with Leber congenital amaurosis
por: Surl, Dongheon, et al.
Publicado: (2020)

Determining multiallelic complex copy number and sequence variation from high coverage exome sequencing data
por: Forni, Diego, et al.
Publicado: (2015)

Multiallelic models for QTL mapping in diverse polyploid populations
por: Thérèse Navarro, Alejandro, et al.
Publicado: (2022)

Association of the del443ins54 at the ARMS2 locus in Indian and Australian cohorts with age-related macular degeneration
por: Kaur, Inderjeet, et al.
Publicado: (2013)

Technical considerations for genotyping multi-allelic copy number variation (CNV), in regions of segmental duplication
por: Cantsilieris, Stuart, et al.
Publicado: (2014)

Repeated Adaptive Introgression at a Gene under Multiallelic Balancing Selection
por: Castric, Vincent, et al.
Publicado: (2008)

Baseline characteristics and age-related macular degeneration in participants of the “ASPirin in Reducing Events in the Elderly” (ASPREE)-AMD trial
por: Robman, Liubov D., et al.
Publicado: (2020)

Pleiotropic Locus 15q24.1 Reveals a Gender-Specific Association with Neovascular but Not Atrophic Age-Related Macular Degeneration (AMD)
por: Kiel, Christina, et al.
Publicado: (2020)

DRD4 48 bp multiallelic variants as age-population-specific biomarkers in attention-deficit/hyperactivity disorder
por: Bonvicini, Cristian, et al.
Publicado: (2020)

Complement Activation Levels Are Related to Disease Stage in AMD
por: Heesterbeek, Thomas J., et al.
Publicado: (2020)

Tapping Stem Cells to Target AMD: Challenges and Prospects
por: Brandl, Caroline, et al.
Publicado: (2015)

MIDAS: software for analysis and visualisation of interallelic disequilibrium between multiallelic markers
por: Gaunt, Tom R, et al.
Publicado: (2006)

Multiallelic models of genetic effects and variance decomposition in non-equilibrium populations
por: Álvarez-Castro, José M., et al.
Publicado: (2011)

A straightforward multiallelic significance test for the Hardy-Weinberg equilibrium law
por: Lauretto, Marcelo S., et al.
Publicado: (2009)

Mathematical constraints on F(ST): multiallelic markers in arbitrarily many populations
por: Alcala, Nicolas, et al.
Publicado: (2022)

Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
por: García-Onrubia, Luis, et al.
Publicado: (2020)

Higher plasma levels of complement C3a, C4a and C5a increase the risk of subretinal fibrosis in neovascular age-related macular degeneration: Complement activation in AMD
por: Lechner, Judith, et al.
Publicado: (2016)

Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study
por: Robman, Liubov, et al.
Publicado: (2017)

Identification of a Rare Coding Variant in Complement 3 Associated with Age-related Macular Degeneration
por: Zhan, Xiaowei, et al.
Publicado: (2013)

Artificial Intelligence to Stratify Severity of Age-Related Macular Degeneration (AMD) and Predict Risk of Progression to Late AMD
por: Bhuiyan, Alauddin, et al.
Publicado: (2020)

AMD and the alternative complement pathway: genetics and functional implications
por: Tan, Perciliz L., et al.
Publicado: (2016)

eLD: entropy-based linkage disequilibrium index between multiallelic sites
por: Okada, Yukinori
Publicado: (2018)

AMD3100/CXCR4 Inhibitor
por: De Clercq, Erik
Publicado: (2015)

The role of lipocalin-2 in age-related macular degeneration (AMD)
por: Ghosh, Sayan, et al.
Publicado: (2020)

Chemoprevention of age-related macular regeneration (AMD) with rapamycin
por: Zheng, X. F. Steven
Publicado: (2012)

Comparison of Visual Function Tests in Intermediate Age-Related Macular Degeneration
por: Guymer, Robyn H., et al.
Publicado: (2021)

Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
por: Hurley, Susan F, et al.
Publicado: (2008)

Differential Expression of Complement Markers in Normal and AMD Transmitochondrial Cybrids
por: Nashine, Sonali, et al.
Publicado: (2016)

Cost-effectiveness of smoking cessation to prevent age-related macular degeneration
por: Hurley, Susan F, et al.
Publicado: (2008)

Copy number variation in the complement factor H-related genes and age-related macular degeneration
por: Kubista, Katharina E., et al.
Publicado: (2011)

Sex Differences in RANTES (CCL5) in Patients With Intermediate Age-Related Macular Degeneration (AMD) and Controls With no AMD
por: Fonteh, Cheryl N., et al.
Publicado: (2022)

Binding of Gtf2i-β/δ transcription factors to the ARMS2 gene leads to increased circulating HTRA1 in AMD patients and in vitro
por: Pan, Yang, et al.
Publicado: (2021)

MOBILIZATION STUDIES IN COMPLEMENT-DEFICIENT MICE REVEAL THAT OPTIMAL AMD3100 MOBILIZATION OF HEMATOPOIETIC STEM CELLS DEPENDS ON COMPLEMENT CASCADE ACTIVATION BY AMD3100-STIMULATED GRANULOCYTES
por: Lee, HakMo, et al.
Publicado: (2009)

Age-Related Macular Degeneration (AMD): A View to the Future
por: Miller, Joan W., et al.
Publicado: (2021)

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
por: Nashine, Sonali
Publicado: (2021)

Can HMG Co-A reductase inhibitors (“statins”) slow the progression of age-related macular degeneration? The Age-Related Maculopathy Statin Study (ARMSS)
por: Guymer, Robyn H, et al.
Publicado: (2008)

Association Study of Mannose-Binding Lectin Levels and Genetic Variants in Lectin Pathway Proteins with Susceptibility to Age-Related Macular Degeneration: A Case-Control Study
por: Osthoff, Michael, et al.
Publicado: (2015)

Deep learning model for automatic differentiation of EMAP from AMD in macular atrophy
por: Chouraqui, Maxime, et al.
Publicado: (2023)

Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration
por: Lad, Eleonora M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4bklmdhhng97hdt2cic6jt9bpq